GKOS vs. TMDX
Compare and contrast key facts about Glaukos Corporation (GKOS) and TransMedics Group, Inc. (TMDX).
Performance
GKOS vs. TMDX - Performance Comparison
Loading graphics...
GKOS vs. TMDX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
GKOS Glaukos Corporation | -4.65% | -24.70% | 88.63% | 81.98% | -1.71% | -40.95% | 38.17% | -23.41% |
TMDX TransMedics Group, Inc. | -18.28% | 95.11% | -21.01% | 27.88% | 222.13% | -3.72% | 4.68% | -14.98% |
Fundamentals
GKOS:
$6.19B
TMDX:
$4.07B
GKOS:
-$3.28
TMDX:
$4.67
GKOS:
12.13
TMDX:
6.69
GKOS:
9.44
TMDX:
8.60
GKOS:
$507.44M
TMDX:
$605.49M
GKOS:
$282.76M
TMDX:
$362.81M
GKOS:
-$156.42M
TMDX:
$137.31M
Returns By Period
In the year-to-date period, GKOS achieves a -4.65% return, which is significantly higher than TMDX's -18.28% return.
GKOS
- 1D
- 2.52%
- 1M
- -10.58%
- YTD
- -4.65%
- 6M
- 32.02%
- 1Y
- 9.39%
- 3Y*
- 29.04%
- 5Y*
- 5.60%
- 10Y*
- 20.17%
TMDX
- 1D
- 5.41%
- 1M
- -31.56%
- YTD
- -18.28%
- 6M
- -11.40%
- 1Y
- 47.76%
- 3Y*
- 9.49%
- 5Y*
- 19.93%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GKOS vs. TMDX — Risk / Return Rank
GKOS
TMDX
GKOS vs. TMDX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Glaukos Corporation (GKOS) and TransMedics Group, Inc. (TMDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GKOS | TMDX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.19 | 0.84 | -0.66 |
Sortino ratioReturn per unit of downside risk | 0.64 | 1.60 | -0.96 |
Omega ratioGain probability vs. loss probability | 1.08 | 1.19 | -0.11 |
Calmar ratioReturn relative to maximum drawdown | 0.19 | 1.21 | -1.02 |
Martin ratioReturn relative to average drawdown | 0.43 | 3.07 | -2.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GKOS | TMDX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.19 | 0.84 | -0.66 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.12 | 0.28 | -0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.39 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.34 | -0.11 |
Correlation
The correlation between GKOS and TMDX is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
GKOS vs. TMDX - Dividend Comparison
Neither GKOS nor TMDX has paid dividends to shareholders.
Drawdowns
GKOS vs. TMDX - Drawdown Comparison
The maximum GKOS drawdown since its inception was -69.57%, smaller than the maximum TMDX drawdown of -73.69%. Use the drawdown chart below to compare losses from any high point for GKOS and TMDX.
Loading graphics...
Drawdown Indicators
| GKOS | TMDX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.57% | -73.69% | +4.12% |
Max Drawdown (1Y)Largest decline over 1 year | -29.92% | -37.30% | +7.38% |
Max Drawdown (5Y)Largest decline over 5 years | -64.32% | -68.60% | +4.28% |
Max Drawdown (10Y)Largest decline over 10 years | -69.57% | — | — |
Current DrawdownCurrent decline from peak | -33.22% | -43.55% | +10.33% |
Average DrawdownAverage peak-to-trough decline | -27.87% | -31.36% | +3.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.03% | 14.62% | -1.59% |
Volatility
GKOS vs. TMDX - Volatility Comparison
The current volatility for Glaukos Corporation (GKOS) is 13.32%, while TransMedics Group, Inc. (TMDX) has a volatility of 16.85%. This indicates that GKOS experiences smaller price fluctuations and is considered to be less risky than TMDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GKOS | TMDX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.32% | 16.85% | -3.53% |
Volatility (6M)Calculated over the trailing 6-month period | 35.21% | 37.60% | -2.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.21% | 56.94% | -6.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.98% | 71.99% | -23.01% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 52.20% | 71.64% | -19.44% |
Financials
GKOS vs. TMDX - Financials Comparison
This section allows you to compare key financial metrics between Glaukos Corporation and TransMedics Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GKOS vs. TMDX - Profitability Comparison
GKOS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Glaukos Corporation reported a gross profit of -1.52M and revenue of 143.12M. Therefore, the gross margin over that period was -1.1%.
TMDX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, TransMedics Group, Inc. reported a gross profit of 93.41M and revenue of 160.76M. Therefore, the gross margin over that period was 58.1%.
GKOS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Glaukos Corporation reported an operating income of -139.87M and revenue of 143.12M, resulting in an operating margin of -97.7%.
TMDX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, TransMedics Group, Inc. reported an operating income of 21.27M and revenue of 160.76M, resulting in an operating margin of 13.2%.
GKOS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Glaukos Corporation reported a net income of -133.66M and revenue of 143.12M, resulting in a net margin of -93.4%.
TMDX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, TransMedics Group, Inc. reported a net income of 105.38M and revenue of 160.76M, resulting in a net margin of 65.6%.